Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone vs DES vs BMS for Coronary Artery Disease
NCT00369356Phase 3Completed
- Sponsor
- Università degli Studi di Verona
- Start
- Oct 2006
- Primary completion
- Oct 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of prednisone in coronary artery disease (CAD) (3 arms), sponsored by Università degli Studi di Verona. Primary endpoint: Major Adverse Cardiac Events at 12 months. Started Oct 2006; status: completed.
02
Drugs
prednisone
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00369356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00369356.